Radnostix Valuation Multiples

Radnostix Overview

About Radnostix

Radnostix Inc is a U.S.-based manufacturer and world-wide supplier of nuclear medicine products, medical devices, and calibration standards. The company operates in North America, Europe, Latin America, and Asia. Its brands include: International Isotopes, RadQual, Phanqual, and Radvent. Each brand deliveris high-quality products and services to the nuclear medicine, molecular imaging, radiopharmaceutical, and respiratory care markets.

Founded

1995

HQ

Employees

42

Website

radnostix.com

Financials (FY)

Revenue: $13M

EBITDA: ($166K)

EV

$37M

Valuation Multiples

Start free trial

Radnostix Financials

Radnostix reported last fiscal year revenue of $13M and negative EBITDA of ($166K).

In the same fiscal year, Radnostix generated $8M in gross profit, ($166K) in EBITDA losses, and had net loss of ($908K).

Radnostix P&L

In the most recent fiscal year, Radnostix reported revenue of $13M and EBITDA of ($166K).

Radnostix is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of (1%), and net margin of (7%).

Radnostix Stock Performance

Radnostix has current market cap of $33M, and enterprise value of $37M.

Radnostix's stock price is $0.06.

Radnostix Valuation Multiples

Radnostix trades at 2.8x EV/Revenue multiple, and (221.7x) EV/EBITDA.

Radnostix Financial Valuation Multiples

As of July 9, 2026, Radnostix has market cap of $33M and EV of $37M.

Radnostix has a P/E ratio of (36.9x).

Radnostix Margins & Growth Rates

In the most recent fiscal year, Radnostix reported gross margin of 59%, EBITDA margin of (1%), and net margin of (7%).

Radnostix Operational KPIs

Radnostix's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Acquisitions by Radnostix

Radnostix has acquired 1 company to date.

Last acquisition by Radnostix was on July 1st 2026. Radnostix acquired Lucerno Dynamics (certain assets) for $2M (EV/Revenue multiple available to Pro users).